Reference | Participants | Study design | Diagnosis of FM | Treatment group | Control group | Study duration | Outcomes | Findings |
---|---|---|---|---|---|---|---|---|
Bojner-Horwitz et al. (2003) [36] | N = 36 | RCT | ACR 1990 | Dance/movement | Waiting control | 14 months | PRL, NPY, DHEA-S, cortisol | The levels of serum PRL in both groups increased across the study interval, with the largest increase in the intervention group |
Mean age: | (n = 20) | (n = 16) | 4 time points (at baseline, and at months 4, 6, and 14 of the study) | |||||
57 ± 7.2 years (total) | 6 months | 6 months | There were no significant differences between baseline and 14 months in the levels of serum PRL between the two groups | |||||
Gender: | once a week | |||||||
female only | 1 h each | serum, saliva | The levels of serum NPY in both groups increased from baseline to month 4, decreased from months 4 − 6, and increased from months 6 − 14 | |||||
There were no significant differences in the levels of serum NPY between the two groups across the study interval | ||||||||
Lund et al. (2006) [32] | N = 19 | RCT | ACR 1990 | Massage | Guided relaxation | 10 weeks | CRF-LI | In the massage group, the concentrations of urinary CRF-LI decreased after 6 weeks of massage treatment (p = 0.01) and 1 month after completion of treatments (p <0.5) |
Mean age: | (n = 10) | (n = 9) | 3 time points (prior to treatment, after 6-week treatment and 1 month after completed treatment) urine | |||||
50.7 ± 9.7 years (total) | 6 weeks | 6 weeks | ||||||
Gender: | twice weekly | twice weekly | ||||||
f+emale only | 30 minutes each (feet and legs 18 minutes, hands and arm 8 minutes, face 4 minutes) | 30 minutes each | ||||||
Bjersing et al. (2012) [26] | N = 49 | RCT | ACR 1990 | Nordic walking | Active control: low-intensity walking | 30 weeks | SP, NPY, | The change in the levels of serum IGF-1 correlated positively with alterations in CSF SP (p <0.1), NPY (p <0.01) and pain threshold (p <0.1) |
Mean age: | (N = 26) | (n = 23) | IL-6, IL-8, IGF-1, IGFBP3, NGF, MMP-3 | |||||
52 years (total) | 15 weeks | 15 weeks | 3 time points | |||||
Gender: | twice a week | twice a week | (baseline, after 15 weeks of exercise, 30 weeks of follow up) | |||||
female only | 40–45 minutes each | 40–45 minutes each | ||||||
serum, CSF | ||||||||
Bazzichi et al. (2013) [33] | N = 41 | RCT | ACR 1990 | Balneotherapy | Active control: mud-bath therapy | 12 weeks | BDNF, oxytocin, | The concentrations of serum BDNF significantly decreased in both balneo-therapy and mud-bath therapy after 12 weeks (p < 0.05, p < 0.01, respectively), while there was no significant change in the levels of oxytocin. |
Mean age: | (n = 20) | (n = 21) | SERT binding parameters, ATP | |||||
54.0 ± 7.2 years (balneotherapy) | 2 weeks | 2 weeks | 3 time points | |||||
52.8 ± 10.2 years (mud-bath therapy) | 6 days a week | 6 days a week | (at baseline, after 2 weeks and after 12 weeks) | |||||
Gender: | 20 minutes each | 20 minutes each (mud pack 10 minutes and immersion in thermal water 10 minutes) | ||||||
19/1 female/male (balneotherapy) | plasma, serum, salivary adiponectin, leptin, resistin, NPY, IGF-1, IGFBP3, NGF | |||||||
20/1 female/male (mud-bath therapy) | ||||||||
Bjersing et al. (2013) [27] | N = 48 | RCT | ACR 1990 | Nordic walking | Active control: low-intensity walking | 30 weeks | The levels of serum resistin increased in the group as a whole after 30 weeks (p <0.05) which correlated with decreased fatigue | |
Mean age: | (n = 26) | (n = 22) | ||||||
52.0 years (lean group) | (lean 4, overweight 15, obese 7) | (lean 5, overweight 11, obese 6) | 3 time points | The levels of serum NPY increased in the group as a whole after 30 weeks (p <0.05). This increase was only significant in obese patients (p <0.05) | ||||
(BMI 18.5 to 24.9, n = 9) | 15 weeks | 15 weeks | (baseline, after 15 weeks of exercise, 30 weeks of follow up) serum, CSF | |||||
53.0 years (overweight group) | twice a week | twice a week | ||||||
(BMI 25 to 29.9, n = 26) | 40–45 minutes each | 40–45 minutes each | ||||||
51.0 years (obese group) | ||||||||
(BMI ≥30, n = 13) | ||||||||
Gender: | ||||||||
female only |